SynCardia

CEO - Patrick Schnegelsberg
CEO - Patrick Schnegelsberg
USA | Funding: $39.4M (+)

Website: http://www.syncardia.com/

SynCardia Systems is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.